Glycotex Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
6/27/2011 7:59:51 AM
More...
|
Glycotex Inc. Awarded Cash Grant Under the U.S. Government Qualifying Therapeutic Discovery Program
11/24/2010 6:48:02 AM
More...
|
Glycotex Inc. Expands Patent Portfolio in Advanced Wound Healing Indications
2/11/2010 10:20:39 AM
More...
|
Glycotex Inc.'s Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis
4/7/2009 9:02:42 AM
More...
|
Glycotex Inc. Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
10/21/2008 8:45:21 AM
More...
|
Glycotex Inc. Finalizes Collaboration Agreement with Advanced Medical Solutions Group plc (AMS)
10/17/2008 11:44:48 AM
More...
|
Glycotex Inc. Completes Enrollment in Phase IIa Study of Lead Product Candidate GLYC-101 for Wound Healing
3/13/2008 8:26:11 AM
More...
|
Glycotex Inc. Receives $0.5 Million From Second Tranche of Private Share Placement
1/16/2008 8:52:58 AM
More...
|
Glycotex Inc. Obtains Active IND From US FDA for GLYC-101 Wound Healing Compound
1/8/2008 9:55:49 AM
More...
|
Novogen Limited (NVGN) Subsidiary Glycotex Inc. Receives Additional Funding
2/27/2007 2:38:35 PM
More...
|
|